A detailed history of Strs Ohio transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Strs Ohio holds 163,000 shares of HBIO stock, worth $373,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
163,000
Previous 154,000 5.84%
Holding current value
$373,270
Previous $438,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$2.64 - $3.54 $23,760 - $31,860
9,000 Added 5.84%
163,000 $438,000
Q2 2024

Aug 05, 2024

BUY
$2.77 - $4.63 $107,476 - $179,644
38,800 Added 33.68%
154,000 $438,000
Q1 2024

May 13, 2024

BUY
$4.02 - $5.39 $41,807 - $56,056
10,400 Added 9.92%
115,200 $488,000
Q4 2023

Jan 30, 2024

SELL
$4.0 - $5.49 $82,400 - $113,094
-20,600 Reduced 16.43%
104,800 $560,000
Q3 2023

Oct 26, 2023

BUY
$4.0 - $5.82 $135,600 - $197,298
33,900 Added 37.05%
125,400 $539,000
Q2 2023

Jul 31, 2023

BUY
$4.19 - $6.16 $383,385 - $563,640
91,500 New
91,500 $502,000
Q2 2022

Jul 25, 2022

SELL
$3.28 - $6.42 $373,920 - $731,880
-114,000 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$5.16 - $7.14 $48,504 - $67,116
9,400 Added 8.99%
114,000 $707,000
Q4 2021

Jan 24, 2022

BUY
$6.37 - $8.18 $45,864 - $58,896
7,200 Added 7.39%
104,600 $737,000
Q3 2021

Oct 22, 2021

SELL
$6.98 - $8.47 $56,538 - $68,607
-8,100 Reduced 7.68%
97,400 $679,000
Q2 2021

Jul 26, 2021

SELL
$5.44 - $8.4 $29,376 - $45,360
-5,400 Reduced 4.87%
105,500 $878,000
Q1 2021

Apr 23, 2021

SELL
$3.91 - $6.99 $148,189 - $264,921
-37,900 Reduced 25.47%
110,900 $605,000
Q4 2020

Jan 25, 2021

SELL
$3.0 - $4.5 $32,700 - $49,050
-10,900 Reduced 6.83%
148,800 $638,000
Q3 2020

Dec 14, 2020

BUY
$2.75 - $4.2 $12,650 - $19,320
4,600 Added 2.97%
159,700 $480,000
Q2 2020

Jul 23, 2020

BUY
$2.12 - $3.14 $328,812 - $487,014
155,100 New
155,100 $480,000
Q3 2019

Oct 21, 2019

SELL
$1.59 - $3.47 $0 - $0
0 Closed
0 $0
Q2 2019

Jul 25, 2019

SELL
$1.93 - $4.59 $281,973 - $670,599
-146,100 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$3.03 - $5.0 $149,739 - $247,095
49,419 Added 51.12%
146,100 $464,000
Q3 2018

Oct 19, 2018

BUY
$5.0 - $6.65 $86,405 - $114,918
17,281 Added 21.76%
96,681 $507,000
Q2 2018

Aug 06, 2018

BUY
$4.2 - $5.95 $333,480 - $472,430
79,400 New
79,400 $424,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $95.3M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.